top of page

BioVenture VoiCes Episode 27: Avalon Bioventures' Jay Lichter

  • blonca9
  • Oct 19
  • 1 min read

Jay Lichter describes his roots growing up in Chicago, Yale, and an early career role at DuPont Merck before getting a call from Kevin Kinsella to try the world of venture at Avalon. Since that pivotal move, he describes numerous companies he either operated or funded, leading to his work today at Avalon Bioventures.




Chapters

Early life – Chicago, Yale, DuPont Merck – 1:40

Joining Kevin Kinsella and moving to the west coast - 7:16

Sequana – 10:46

French company and Pfizer – 15:29

Avalon, joining formally and raising new funds – 21:41

Community of Innovation (COI) – 26:57

Synthorx – 34:25

Starting Avalon Bioventures – 44:45

Janux – 49:05

Avalon Bioventures Today – 53:02

San Diego Biotech – 57:41

Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTV

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

evaluate-logo-png_seeklogo-457165-2_edited.png

Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.

​

​Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.

Learn more about Evaluate

bottom of page